Lawfirm | Lawyer

Michael R. King adds upstream expertise to the firm's oil and gas industry practice Latham & Watkins LLP1 is pleased to announce that Michael R.

Watson Pharmaceuticals, Inc. and Actavis Group have jointly announced that Watson has entered into a definitive agreement to acquire privately held Actavis for an upfront payment of EUR4.25 billion. Actavis has operations in more than 40 countries and presently has a portfolio which includes more than 1,000 medicines present on the market and registered in more than 70 countries. As a result of the transaction, Watson will become the third largest global generics company, with 2012 anticipated ...

The Kyiv office of DLA Piper is again shortlisted among finalists for "Ukraine Tax Firm of the Year" nomination at the European Tax Awards 2012.